Cambridge has been part of a successful £16 million bid to work with the MRC, GSK and four other UK universities in a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases that present a serious burden to patients. The Experimental Medicine Initiative to Explore New Therapies (EMINENT) network will be […]
TRANSLATIONAL RESEARCH FUNDERS VISIT
Are you thinking of developing or trialling a new medicine, medical device, diagnostic or surgical intervention? Would you like to find out more about what funding schemes are available to support you in this? The Office for Translational Research and Cambridge Clinical Trials Unit Invite you to a Funders Visit TRANSLATIONAL BIOMEDICAL RESEARCH […]
Cambridge New Therapeutics Forum (CamNTF)
Date: Thursday, 18 June 2015 Time: 17.30 – 20.00Address: Wellcome Genome Campus, Hinxton, Cambridges Registration will open shortly, in the interim please register your interest at info@onenucleus.com Speakers: Ewan Birney (European Bioinfomatics Institute) – Big Data and translational bioinformaticsTrevor Lawley (Wellcome Trust Sanger Institute) – Human microbiomes A scientific forum open to all scientists interested in research and development […]
Cambridge New Therapeutics Forum (CamNTF)
Date: Tuesday, 13 October 2015Time: 17.30 – 20.00Address: Astex Pharmaceuticals, 436 Cambridge Science Park, Cambridge CB4 0QARegistration will open shortly, in the interim please register your interest at info@onenucleus.com Speakers: Sir Tom Blundell, University of CambridgeSir Greg Winter, University of Cambridge A scientific forum open to all scientists interested in research and development of new therapeutics in […]
Cambridge New Therapeutics Forum (CamNTF)
Date: Tuesday, 8 December 2015Time: 17.30 – 20.00Address: Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge Biomedical Campus, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RETo register please click here. Speakers Professor John Todd, University of Cambridge Professor Alastair Compston, University of Cambridge A scientific forum open to all scientists interested in research […]
Are you an immunologist looking for a unique sabbatical opportunity?
The GSK Elion and Black Immunology Catalyst Sabbatical programme is designed to drive major breakthroughs in applied immunology and broaden scientific insight. It provides the opportunity to explore independent research at GSK, with access to their technology, tools and reagents, and access to the collective expertise and creativity of GSK’s multi-disciplinary scientists, who are regularly published in leading journals […]
MRC experimental medicine challenge grants: discovery science in humans
This is a call for ambitious programmes of research into disease pathophysiology, conducted in humans. The deadline for outlines is the 25th of June. For more information please click here
Computer-aided Drug Design Workshop
A hands-on computer-aided drug design workshop. Inhibitor Design Using MOE SBDD ApplicationsVisualization / Pharmacophores / Docking / Combinatorial synthesis Biologics Modeling for Protein EngineeringAntibody modeling / Virtual residue scanning / Building fusion proteins / Loop grafting and conformational searching There is no cost to attend this workshop but pre-registration is required as seats are limited. No previous MOE software experience is […]
GSK Discovery Partnerships with Academia (DPAc) Presentation
Monday 23rd February 2015, 10-11am, School of Clinical Medicine (followed by informal networking and question and answer sessions 11-11.30am & bookable 1:1 sessions 11.30-3pm) Dr Duncan Holmes (Head of DPAc, Europe) and Dr Jeremy Griggs (DPAc Leader, Biology, Europe) will be coming back to visit the University of Cambridge to present the GSK Discovery […]
GSK Presentation
Would you like to collaborate with GSK? Do you want to find out what GSK’s interests are? An event to highlight GSK’s research areas of interest and inform Cambridge researchers how they can engage with GSK to establish collaborative research projects. Open presentation by GSK scientific leaders: Ian Tomlinson Head Worldwide Business Development […]
